Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VELTASSA® safely and effectively. See full prescribing information for VELTASSA. VELTASSA (patiromer) for oral suspensionInitial U.S. Approval: 2015
Medication labelWhy this: Advisory · dailymed-prescription
Veltassa is indicated for the treatment of hyperkalemia in adults and pediatric patients ages 12 years and older. Limitation of Use: Veltassa should not be used as an emergency treatment for life-threatening hyperkalemia because of its delayed onset of action [see Clinical Pharmacology (12.2)].
- generic_name
- patiromer
- product_names
- patiromer
- ndc
- 53436-084, 53436-084-01, 53436-084-04, 53436-084-30, 53436-084-91, 53436-084-92, 53436-168, 53436-168-01, 53436-168-30, 53436-252, 53436-252-01, 53436-252-30, 53436-010, 53436-010-01, 53436-010-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en